News | April 26, 2012

SCAI Attendees Discuss Strategies to Reduce Costs, Eliminate Waste, Ensure Appropriate Use

April 26, 2012 — Interventional cardiologists can and should lead efforts to improve quality, cut costs and ensure appropriate use of procedures. Elliott Fisher, M.D., MPH, professor of medicine at Dartmouth, an internationally recognized expert on variations in health system performance and one of the originators of the concept of accountable care organizations, will challenge the interventional cardiology community to accomplish these and other goals at a town hall meeting during the 2012 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) in Las Vegas. His keynote address, “Why Interventional Cardiology Needs to be a Change Leader,” will set the stage for an interactive discussion with cardiologists attending the conference.

In his keynote address, Fisher will speak about the need for payment reform, the future of healthcare, why these changes are critical now and how interventional cardiologists can help lead the successful transformation of the U.S. healthcare system.

“Our health system simply cannot afford to continue the same patterns and models of care delivery that we have relied on in decades past,” said Fisher. “As physicians, we need to be leading the effort to put the systems in place that will result in both improved patient care and reduced costs. As a specialty, interventional cardiology has led the way in evidence-based care and quality improvement. I intend to deliver a message of challenge, hope and choice — and by that I mean, face up to our current fiscal predicament, realize this is a moment of opportunity and make the choice to fix it. If interventional cardiologists do this, they will be demonstrating to the larger healthcare community how these things can be done.”

An open discussion about the state of interventional cardiology will follow the keynote, featuring a panel of leading interventional cardiologists. Town hall faculty will share specific examples of how interventional cardiologists can continue their efforts to improve safety and quality through quality improvement initiatives, such as:

- Lessons from recent cases of alleged inappropriate and overuse of stenting in Maryland, presented by Mark Turco, M.D., FSCAI
- Cath lab accreditation to promote quality improvement in interventional cardiology, presented by Accreditation for Cardiovascular Excellence (ACE) Chief Medical Officer Bonnie Weiner, M.D., FSCAI
- SCAI’s Quality Improvement Toolkit (QIT), featuring guidelines and tools focused on peer-review conferences, random case selection, national database participation, pre-procedure checklists and other tools to aid in continuous quality improvement, presented by Jeffrey Marshall, M.D., FSCAI
- SCAI’s appropriate use criteria (AUC) smartphone application, providing interventional cardiologists easy access to relevant guidelines and the ability to instantaneously calculate “appropriateness,” presented by Kalon Ho, M.D., FSCAI

“Already the interventional cardiology community is leading important initiatives aimed at improving the quality of care. The vast majority of us are deeply committed to doing the right thing for our patients,” said SCAI 2012 program co-director Kenneth Rosenfield,
M.D., FSCAI. “Now we need all interventional cardiologists to join together in this mission. We have the opportunity to make a significant impact on cost and value in our profession and in the larger healthcare system.”

An interactive discussion with attendees will follow the presentations. The Town Hall session will take place Friday, May 11, 2012 from 11 a.m. to 12:45 p.m. (Pacific time).

For more information: www.scai.org

Related Content

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Overlay Init